Who needs acetate-free biofiltration?
Acetate-free biofiltration (AFB) is a hemodiafiltration (HDF) technique that is performed with a base-free dialysate and simultaneous infusion of sodium bicarbonate solution. In Japan 3 years ago, a new form of acetate-free dialysate containing 2.0 mEq/l citric acid was approved. Recently, we have had a 76-year-old male subject who switched from AFHD to AFB, mainly because of cardiovascular stability. Several factors may contribute to hemodynamic adaptation during AFB. One theory is that an increase in peripheral vascular tone and vascular refilling rate is caused by the high sodium concentration of the substitution fluid. AFB has all the premises for being a perfectly biocompatible technique capable of satisfying even the demands of critical patients laden with comorbidities.